Clinical Trial 23645

A Phase 1 Study of XB628 in Participants With Recurrent Advanced or Metastatic Solid Tumors

Disease Site: Any Site, Cervix, Corpus Uteri, Other Female Genital, Other Male Genital, Other Urinary, Ovary, Prostate, Urinary Bladder

PI: Park, Robin

Clinical Trial 23660

A Phase 1 Study of MOMA-341 as Monotherapy or Combination Therapy in Participants with Advanced or Metastatic Solid Tumors

Disease Site: Anus, Any Site, Colon, Corpus Uteri, Esophagus, Other Digestive Organ, Rectum

PI: Biachi de Castria, Tiago

Clinical Trial 23735

The CAROLYN Trial: Lisocabtagene Maraleucel as First-Line Therapy for Primary Central Nervous System Lymphoma (PCNSL) in Transplant-Ineligible Patients

Disease Site: Non-Hodgkin's Lymphoma

PI: Jain, Michael

Clinical Trial 23766

A First-in-Human Phase 1 Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of FID-022 as Monotherapy in Patients with Advanced Solid Tumors

Disease Site: Anus, Any Site, Breast, Colon, Esophagus, Larynx, Lip, Oral Cavity and Pharynx, Lung, Rectum, Small Intestine, Soft Tissue, Stomach

PI: Rabinowits, Guilherme

Clinical Trial 23912

A Modular, Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120, a Dual-targeting Autologous Chimeric Antigen Receptor T-cell (CAR-T) Therapy Directed Against BCMA and CD-19 in Participants with Multiple Myeloma

Disease Site: Bones and Joints

PI: Alsina, Melissa

Clinical Trial 20938

A Randomized Phase II Trial of Adjuvant Pembrolizumab Versus Observation Following Curative Resection for Stage I Non-Small Cell Lung Cancer (NSCLC) with Primary Tumors Between 1-4 cm

Disease Site: Lung

PI: Chiappori, Alberto

Clinical Trial 21056

A Phase 1b/2, Open-Label, Safety and Efficacy Study of Epcoritamab (GEN3013; DuoBody®-CD3 X CD20) in Relapsed/Refractory Chronic Lymphocytic Leukemia

Disease Site: Lymphoid Leukemia

PI: Sandoval-Sus, Jose

Clinical Trial 21996

An Open-Label, Multicenter, Phase 1b/2 Study of RP1 in Solid Organ Transplant Recipients with Advanced Cutaneous Malignancies

Disease Site: Other Skin

PI: Khushalani, Nikhil

Clinical Trial 20752

A Phase 1 Study of Vyxeos Plus Gilteritinib in Relapsed or Refractory, FLT3-Mutated Acute Myeloid Leukemia

Disease Site: Leukemia, other, Myeloid and Monocytic Leukemia

PI: Chan, Onyee

Clinical Trial 22079

A Phase 1/2, Open-Label Study of PD-1 Knockout Tumor-Infiltrating Lymphocytes (IOC-4001) in Participants with Unresectable or Metastatic Melanoma or Stage III or IV Non-Small-Cell Lung Cancer

Disease Site: Lung, Melanoma, skin

PI: Karapetyan, Lilit

Clinical Trial 90038

Disease Site: Other Hematopoietic

PI: Deutsch, Yehuda

Clinical Trial 23176

A Phase 2, randomised, open label, multicentre study of an intraperitoneal alpha-emitting radionuclide therapy (Radspherin®) in patients with primary advanced high-grade serous or high-grade endometrioid epithelial ovarian, fallopian tube, or primary peritoneal cancer, with peritoneal metastasis that are homologous recombination proficient and scheduled to undergo neoadjuvant chemotherapy and interval debulking surgery

Disease Site: Other Female Genital, Ovary, Reproductive System

PI: Chon, Hye Sook

Clinical Trials Search Results

366 Clinical Trials Found

Clinical Trials Search Results

Clinical Trial Search

366 Clinical Trials Found

Cambiar el idioma